Vitaeris, Inc. is a company that provides Clazakizumab, Monoclonal antibody, Chronic inflammatory disease and more. Vitaeris, Inc. is headquartered in Canada British Columbia. Vitaeris, Inc. was founded in 2016. Vitaeris, Inc. has a total of 107 patents
Vitaeris has licensed global exclusive rights to the best-in-class anti-interleukin-6 monoclonal antibody Clazakizumab from Alder Biopharmaceuticals, and...
What is Vitaeris, Inc.'s official website?
Vitaeris, Inc.'s official website is http://www.vitaerisbio.com.